Proteomic analysis of CD8<sup>+</sup> T lymphocytes in peripheral blood across different breast cancer subtypes provides a comprehensive view of the molecular mechanisms of the systemic immune response that can significantly contribute to advancements in the diagnosis, treatment, and prognosis of this disease. This evidence concerns the gene CD8A and breast cancer.